1. Home
  2. TGL vs XBIO Comparison

TGL vs XBIO Comparison

Compare TGL & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGL

Treasure Global Inc.

HOLD

Current Price

$3.65

Market Cap

6.7M

Sector

Technology

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.15

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGL
XBIO
Founded
2020
N/A
Country
United States
United States
Employees
N/A
2
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
TGL
XBIO
Price
$3.65
$3.15
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
38.5K
22.4K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,330,557.00
N/A
Revenue This Year
N/A
$2.81
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$1.90
52 Week High
$58.00
$13.93

Technical Indicators

Market Signals
Indicator
TGL
XBIO
Relative Strength Index (RSI) 41.57 58.50
Support Level $3.40 $2.59
Resistance Level $9.45 $3.12
Average True Range (ATR) 0.35 0.19
MACD 0.04 0.00
Stochastic Oscillator 29.99 69.23

Price Performance

Historical Comparison
TGL
XBIO

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: